alexa Sustained Responses following Treatment with Romiplostim in Immune Thrombocytopenia: A Single-Centre Experience
ISSN: 2329-8790

Journal of Hematology & Thromboembolic Diseases
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Sustained Responses following Treatment with Romiplostim in Immune Thrombocytopenia: A Single-Centre Experience

Drew Provan1*, Louise Taylor2, Raghava Nandigham1, Umesh Doobaree1, Pallavi Kalkur2 and Adrian C Newland1
1Barts and The London School of Medicine and Dentistry, London, UK
2Barts Health NHS Trust, London, El IBB, London, UK
Corresponding Author : Drew Provan
Barts and The London School of Medicine and Dentistry
London, UK
Tel: 92032460339
E-mail: [email protected]
Received May 27, 2014; Accepted June 16, 2014; Published June 25, 2014
Citation: Provan D, Taylor L, Nandigham R, Doobaree U, Kalkur P, et al. (2014) Sustained Responses following Treatment with Romiplostim in Immune Thrombocytopenia: A Single-Centre Experience. J Hematol Thrombo Dis 2:147. doi: 10.4172/2329-8790.1000147
Copyright: © 2014 Provan D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google
 

Abstract

Background: Romiplostim is a thrombopoietin receptor agonist which is useful for the treatment of adults with chronic immune thrombocytopenia. This class of treatment is regarded as palliative, raising platelet counts whilst patients are receiving romiplostim, with the expectation that platelets will return to baseline after stopping therapy. Anecdotal reports have suggested that some patients show unexpected longer term responses when off treatment. Design: We examined the outcomes for 21 consecutively-treated adult patients at our center to determine whether any patients had sustained responses after stopping romiplostim. A platelet count of ≥ 100 x 109/L was considered a complete response, and from 50–100×109/L this was considered a partial response. If the response after stopping romiplostim lasted 6 months or more this was considered a durable response.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords